Clinical Trials Logo

Bioavailability clinical trials

View clinical trials related to Bioavailability.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06177483 Active, not recruiting - Bioavailability Clinical Trials

Bioavailability Evaluation of curQ+ Curcumin Formulation

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

This study is intended to evaluate how significantly a proprietary curcumin formulation (curQ+®) results in greater bioavailability compared to 95% curcumin extract over a 6-hour time period following a single oral dose in healthy men & women.

NCT ID: NCT06098001 Active, not recruiting - Bioavailability Clinical Trials

Bioavailability Study of Hemp Phenolics

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

The aim is to determine the bioavailability of the polyphenol fraction form a commercially available hemp hull fiber at two different amounts in generally healthy adults. Additional objectives include determining specific metabolites produced over a 24 to 48-hour period following the hemp fiber consumption. Subjects will consume a study pudding that will be used to deliver a low and a high dose fiber product. Blood samples will be collected to measure background levels of metabolites. At day 0 participants will consume a low dose study product and day 6 the high dose study product and provide blood samples over an 8 hr period after study product consumption, to be followed by a 24 hr blood sample and 48 hr blood sample. Additionally following the low / high dose study product 24 and 48 h urine samples will be collected.

NCT ID: NCT05361369 Active, not recruiting - Bioavailability Clinical Trials

Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule

Start date: May 9, 2022
Phase: Phase 1
Study type: Interventional

A single dose of the study drug will be administered to healthy female subjects in a single period to obtain pharmacokinetic parameters for each active ingredient.

NCT ID: NCT02231502 Active, not recruiting - Bioavailability Clinical Trials

Innovation in Food Production Techniques to Improve Bioactive Content

ENRICH
Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to establish to what extent innovations in food production techniques may facilitate retention of bioactive compounds in healthy individuals. The study has a single-blinded (outcome assessor), cross-over design; wherein, the plasma concentration and urinary excretion levels of a range of bioactive compounds will be assessed over a 24 hour period following intake of either a vegetable based convenience food, or a minimally processed meal containing the same vegetable materials. To do this, 20 healthy volunteers will attend two assessment days (and a follow-up assessment at +24hr) and will provide blood and urine samples, which will be collected at biologically relevant times over the 24 hour period. In this cross-over study, each meal will be eaten on separate days, with a wash-out period of at least 1 week between assessments.